RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Akira Kawamura to Middle Aged

This is a "connection" page, showing publications Akira Kawamura has written about Middle Aged.
Connection Strength

0.520
  1. Oikawa M, Otake T, Awatani T, Noguchi H, Kawamura A. Impacts of health checkup programs standardization on working-age self-employed and unemployed: Insights from Japan's local government response to national policy. J Health Econ. 2025 Sep; 103:103046.
    View in: PubMed
    Score: 0.082
  2. Kawamura A, Matsunaga A, Fukuda Y, Fujimi K, Kanaya H, Matsuda T. [Report from Kyushu Chapter Educational Seminar: what is cardiac rehabilitation? Case report and short lectures]. Nihon Naika Gakkai Zasshi. 2013 Oct 10; 102(10):2723-32.
    View in: PubMed
    Score: 0.036
  3. Takamiya Y, Imanaga C, Abe I, Kobayashi K, Ike A, Kawamura A, Urata H. Long-term renoprotective effect of luseogliflozin in type 2 diabetes patients: CHikushi Anti-diabetes mellitus Trial-Lusefi (CHAT-Lu). Drug Discov Ther. 2025 Jan 14; 18(6):336-342.
    View in: PubMed
    Score: 0.020
  4. Kariya M, Yamamoto K, Kawamura A, Tanizaki S, Ueda K, Sai K, Hata A. Cystine and theanine for chemoradiotherapy-induced esophagitis in non-small cell lung cancer: a prospective observational study. Support Care Cancer. 2024 Jun 03; 32(6):400.
    View in: PubMed
    Score: 0.019
  5. Kawamura A, Miura S, Murayama T, Iwata A, Zhang B, Nishikawa H, Tsuchiya Y, Matsuo K, Tsuji E, Saku K. Increased expression of monocyte CD11a and intracellular adhesion molecule-1 in patients with initial atherosclerotic coronary stenosis. Circ J. 2004 Jan; 68(1):6-10.
    View in: PubMed
    Score: 0.018
  6. Kawamura A, Miura S, Murayama T, Iwata A, Nishikawa H, Matsuo Y, Tsuchiya Y, Matsuo K, Tsuji E, Saku K. Changes in the expression of leukocyte adhesion molecules throughout the acute phase of myocardial infarction. J Atheroscler Thromb. 2004; 11(1):29-34.
    View in: PubMed
    Score: 0.018
  7. Kawamura A, Miura S, Fujino M, Nishikawa H, Matsuo Y, Tanigawa H, Tomita S, Tsuchiya Y, Matsuo K, Saku K. CXCR3 chemokine receptor-plasma IP10 interaction in patients with coronary artery disease. Circ J. 2003 Oct; 67(10):851-4.
    View in: PubMed
    Score: 0.018
  8. Kawamura A, Adachi K, Takashima T, Fujishiro H, Yuki M, Ishihara S, Kinoshita Y. Helicobacter pylori-independent effect of hyperglycemia on gastric mucosal atrophy. Am J Gastroenterol. 2002 Sep; 97(9):2479-80.
    View in: PubMed
    Score: 0.017
  9. Himoto Y, Sakata A, Kirita M, Hiroi T, Kobayashi KI, Kubo K, Kim H, Nishimoto A, Maeda C, Kawamura A, Komiya N, Umeoka S. Diagnostic performance of chest CT to differentiate COVID-19 pneumonia in non-high-epidemic area in Japan. Jpn J Radiol. 2020 May; 38(5):400-406.
    View in: PubMed
    Score: 0.014
  10. Kaneko S, Noguchi H, Fu R, Kang C, Kawamura A, Amano S, Miyawaki A. Differences in cancer patients' work-cessation risk, based on gender and type of job: Examination of middle-aged and older adults in super-aged Japan. PLoS One. 2020; 15(1):e0227792.
    View in: PubMed
    Score: 0.014
  11. Fu R, Noguchi H, Kaneko S, Kawamura A, Kang C, Takahashi H, Tamiya N. How do cardiovascular diseases harm labor force participation? Evidence of nationally representative survey data from Japan, a super-aged society. PLoS One. 2019; 14(7):e0219149.
    View in: PubMed
    Score: 0.013
  12. Koyoshi R, Hitaka-Yoshimine Y, Shiga Y, Kuwano T, Sugihara M, Ike A, Iwata A, Sako H, Morito N, Kawamura A, Miura SI. Associations between microalbuminuria and parameters of flow-mediated vasodilatation obtained by continuous measurement approaches. Clin Exp Hypertens. 2018; 40(8):715-720.
    View in: PubMed
    Score: 0.012
  13. Matsuoka Y, Ike A, Ogawa M, Gondo K, Shirai K, Sugihara M, Nose D, Nishikawa H, Iwata A, Kawamura A, Mori K, Zhang B, Yasunaga S, Miura SI, Saku K. Sex difference between target levels of cholesterol-related parameters and post-PCI long-term clinical outcomes: From the FU-Registry. J Cardiol. 2018 03; 71(3):259-267.
    View in: PubMed
    Score: 0.012
  14. Fu R, Noguchi H, Kawamura A, Takahashi H, Tamiya N. Spillover effect of Japanese long-term care insurance as an employment promotion policy for family caregivers. J Health Econ. 2017 12; 56:103-112.
    View in: PubMed
    Score: 0.012
  15. Fu R, Noguchi H, Tachikawa H, Aiba M, Nakamine S, Kawamura A, Takahashi H, Tamiya N. Relation between social network and psychological distress among middle-aged adults in Japan: Evidence from a national longitudinal survey. Soc Sci Med. 2017 02; 175:58-65.
    View in: PubMed
    Score: 0.011
  16. Ike A, Shirai K, Nishikawa H, Iwata A, Yahiro E, Sugihara M, Kawamura A, Uehara Y, Zhang B, Ogawa M, Mori K, Miura S, Saku K. Associations between different types of hypoglycemic agents and the clinical outcome of percutaneous coronary intervention in diabetic patients-From the FU-Registry. J Cardiol. 2015 May; 65(5):390-6.
    View in: PubMed
    Score: 0.010
  17. Nagata I, Ike A, Nishikawa H, Zhang B, Sugihara M, Mori K, Iwata A, Kawamura A, Shirai K, Uehara Y, Ogawa M, Miura S, Saku K. Associations between lipid profiles and MACE in hemodialysis patients with percutaneous coronary intervention: from the FU-Registry. J Cardiol. 2015 Feb; 65(2):105-11.
    View in: PubMed
    Score: 0.009
  18. Morii J, Miura S, Ike A, Shiga Y, Sugihara M, Iwata A, Kawamura A, Nishikawa H, Saku K. Comparison of the efficacies of irbesartan and olmesartan after successful coronary stent implantation. Intern Med. 2013; 52(7):713-9.
    View in: PubMed
    Score: 0.009
  19. Sugihara M, Miura S, Nishikawa H, Ike A, Mori K, Iwata A, Kawamura A, Saku K. Characteristics of patients and types of lesions in patients with drug-eluting or bare-metal stent implantation in small coronary arteries: from the FU-Registry. J Cardiol. 2013 Feb; 61(2):117-21.
    View in: PubMed
    Score: 0.008
  20. Iwata A, Miura S, Tanaka T, Ike A, Sugihara M, Nishikawa H, Kawamura A, Saku K. Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin. Coron Artery Dis. 2012 Aug; 23(5):315-21.
    View in: PubMed
    Score: 0.008
  21. Mito T, Miura S, Iwata A, Morii J, Sugihara M, Ike A, Mori K, Kawamura A, Nishikawa H, Zhang B, Saku K. Determination of the cut-off plasma adiponectin level associated with a lower risk of restenosis in patients with stable angina. Coron Artery Dis. 2011 Nov; 22(7):451-7.
    View in: PubMed
    Score: 0.008
  22. Kuwano T, Miura S, Shirai K, Ike A, Mori K, Shimizu T, Zhang B, Iwata A, Nishikawa H, Kawamura A, Saku K. Serum levels of bilirubin as an independent predictor of coronary in-stent restenosis: a new look at an old molecule. J Atheroscler Thromb. 2011; 18(7):574-83.
    View in: PubMed
    Score: 0.008
  23. Sugihara M, Miura S, Takamiya Y, Kiya Y, Arimura T, Iwata A, Kawamura A, Nishikawa H, Yamagishi S, Saku K. Significance of pigment epithelium-derived factor levels with angiotensin II type 1 receptor blockers in patients with successful coronary stent implantation. J Renin Angiotensin Aldosterone Syst. 2011 Sep; 12(3):320-5.
    View in: PubMed
    Score: 0.008
  24. Takamiya Y, Miura S, Tsuchiya Y, Fukuda Y, Zhang B, Kuwano T, Ike A, Yanagi D, Kubota K, Mori K, Iwata A, Nishikawa H, Kawamura A, Miller N, Matsuo K, Shirai K, Saku K. Angiographic late lumen loss at the site of overlap of multiple Cypher? sirolimus-eluting stents: ALSOCE study. J Cardiol. 2011 Mar; 57(2):187-93.
    View in: PubMed
    Score: 0.007
  25. Shiga Y, Miura S, Mitsutake R, Kawamura A, Uehara Y, Saku K. Significance of serum high-density lipoprotein cholesterol levels for diagnosis of coronary stenosis as determined by MDCT in patients with suspected coronary artery disease. J Atheroscler Thromb. 2010 Aug 31; 17(8):870-8.
    View in: PubMed
    Score: 0.007
  26. Fukuda Y, Miura S, Zhang B, Iwata A, Kawamura A, Nishikawa H, Shirai K, Saku K. Significance of urinary liver-fatty acid-binding protein in cardiac catheterization in patients with coronary artery disease. Intern Med. 2009; 48(19):1731-7.
    View in: PubMed
    Score: 0.007
  27. Takamiya Y, Miura S, Kawamura A, Tanigawa H, Zhang B, Iwata A, Nishikawa H, Matsuo K, Shirai K, Saku K. Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease. Coron Artery Dis. 2009 Jun; 20(4):288-94.
    View in: PubMed
    Score: 0.007
  28. Sugihara M, Miura S, Takamiya Y, Kiya Y, Arimura T, Iwata A, Kawamura A, Nishikawa H, Uehara Y, Saku K. Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation. Hypertens Res. 2009 Jul; 32(7):625-30.
    View in: PubMed
    Score: 0.007
  29. Kumagai N, Mitsutake R, Miura S, Kawamura A, Takamiya Y, Nishikawa H, Uehara Y, Saku K. Acute coronary syndrome associated with essential thrombocythemia. J Cardiol. 2009 Dec; 54(3):485-9.
    View in: PubMed
    Score: 0.007
  30. Mitsutake R, Miura S, Kawamura A, Saku K. Are metabolic factors associated with coronary artery stenosis on MDCT? Circ J. 2009 Jan; 73(1):132-8.
    View in: PubMed
    Score: 0.006
  31. Mitsutake R, Miura S, Shiga Y, Kawamura A, Saku K. Is chronic kidney disease associated with coronary artery stenosis or calcification as assessed by multi-detector row computed tomography? Intern Med. 2008; 47(21):1835-41.
    View in: PubMed
    Score: 0.006
  32. Iwata A, Miura S, Mori K, Kawamura A, Nishikawa H, Saku K. Associations between metabolic factors and coronary plaque growth or arterial remodeling as assessed by intravascular ultrasound in patients with stable angina. Hypertens Res. 2008 Oct; 31(10):1879-86.
    View in: PubMed
    Score: 0.006
  33. Kawamura A, Tanaka H. Rickettsiosis in Japan. Jpn J Exp Med. 1988 Aug; 58(4):169-84.
    View in: PubMed
    Score: 0.006
  34. Yanagi D, Shirai K, Takamiya Y, Fukuda Y, Kuwano T, Ike A, Mori K, Kubota K, Iwata A, Fujimi K, Kawamura A, Nishikawa H, Miller N, Zhang B, Tsuchiya Y, Urata H, Saku K. Results of provisional stenting with a Sirolimus-eluting stent for bifurcation lesion: multicenter study in Japan. J Cardiol. 2008 Apr; 51(2):89-94.
    View in: PubMed
    Score: 0.006
  35. Sako H, Miura S, Iwata A, Nishikawa H, Kawamura A, Matsuo K, Shirai K, Saku K. Changes in CCR2 chemokine receptor expression and plasma MCP-1 concentration after the implantation of bare metal stents versus sirolimus-eluting stents in patients with stable angina. Intern Med. 2008; 47(1):7-13.
    View in: PubMed
    Score: 0.006
  36. Mitsutake R, Niimura H, Miura S, Zhang B, Iwata A, Nishikawa H, Kawamura A, Kumagai K, Shirai K, Matsunaga A, Saku K. Clinical significance of the coronary calcification score by multidetector row computed tomography for the evaluation of coronary stenosis in Japanese patients. Circ J. 2006 Sep; 70(9):1122-7.
    View in: PubMed
    Score: 0.006
  37. Iwata A, Miura S, Shirai K, Kawamura A, Tomita S, Matsuo Y, Zhang B, Nishikawa H, Kumagai K, Matsuo K, Saku K. Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction. Intern Med. 2006; 45(15):885-90.
    View in: PubMed
    Score: 0.006
  38. Iwata A, Miura S, Nishikawa H, Kawamura A, Matsuo Y, Sako H, Kumagai K, Matsuo K, Saku K. Significance of combined angiotensin II receptor blocker and carvedilol therapy in patients with congestive heart failure and arginine variant. J Cardiol. 2006 Jan; 47(1):1-7.
    View in: PubMed
    Score: 0.005
  39. Nishikawa H, Miura S, Shimomura H, Kawamura A, Tsujita K, Shirai K, Matsuo K, Arai H, Saku K. Effect of statin on restenosis after radius stent implantation in patients with acute coronary syndrome. J Atheroscler Thromb. 2005; 12(6):302-6.
    View in: PubMed
    Score: 0.005
  40. Adachi K, Arima N, Takashima T, Miyaoka Y, Yuki M, Ono M, Komazawa Y, Kawamura A, Fujishiro H, Ishihara S, Kinoshita Y. Pulse-wave velocity and cardiovascular risk factors in subjects with Helicobacter pylori infection. J Gastroenterol Hepatol. 2003 Jul; 18(7):771-7.
    View in: PubMed
    Score: 0.004
  41. Komazawa Y, Adachi K, Mihara T, Ono M, Kawamura A, Fujishiro H, Kinoshita Y. Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subjects without Helicobacter pylori infection. J Gastroenterol Hepatol. 2003 Jun; 18(6):678-82.
    View in: PubMed
    Score: 0.004
  42. Miura S, Nishikawa H, Zhang B, Matsuo Y, Kawamura A, Tsuchiya Y, Matsuo K, Saku K. Angiotensin-converting enzyme inhibitor promotes coronary collateral circulation in patients with coronary artery disease. Circ J. 2003 Jun; 67(6):535-8.
    View in: PubMed
    Score: 0.004
  43. Takashima T, Adachi K, Kawamura A, Yuki M, Fujishiro H, Rumi MA, Ishihara S, Watanabe M, Kinoshita Y. Cardiovascular risk factors in subjects with Helicobacter pylori infection. Helicobacter. 2002 Apr; 7(2):86-90.
    View in: PubMed
    Score: 0.004
  44. Adachi K, Kawamura A, Ono M, Masuzaki K, Takashima T, Yuki M, Fujishiro H, Ishihara S, Kinoshita Y. Comparative evaluation of urine-based and other minimally invasive methods for the diagnosis of Helicobacter pylori infection. J Gastroenterol. 2002; 37(9):703-8.
    View in: PubMed
    Score: 0.004
  45. Miyairi T, Kijima H, Murata M, Nogami S, Shirasaka A, Tanaka H, Kawamura A. [Shichito fever in Izu Shichito Islands. 4. Incidence of anti-R. tsutsugamushi antibody among inhabitant's sera (author's transl)]. Kansenshogaku Zasshi. 1980 Jun; 54(6):284-90.
    View in: PubMed
    Score: 0.004
  46. Kawamura A, Murata M, Osono M, Nogami S, Shirasaka A, Tanaka H, Sudo K, Suzuki K, Miyairi T, Kijima H. Studies on inapparent infection of tsutsugamuschi disease in Izu Shichito Islands: seroepidemiology and demonstration of an avirulent Rickettsia strain for mice. Jpn J Exp Med. 1980 Apr; 50(2):91-105.
    View in: PubMed
    Score: 0.004
  47. Lynn T, Tu S, Hirayama T, Kawamura A. Nasopharyngeal carcinoma and Epstein-Barr virus. I. Factors related to the anti-VCA antibody. Jpn J Exp Med. 1973 Apr; 43(2):121-33.
    View in: PubMed
    Score: 0.002
  48. Kawamura A, Takada M, Goto A, Hamajima K, Sanpe T. Seroepidemiological studies on nasopharyngeal carcinoma by fluorescent antibody techniques with cultured Burkitt lymphoma cell. Gan. 1970 Feb; 61(1):55-71.
    View in: PubMed
    Score: 0.002
  49. Murata M, Nogami S, Shirasaka A, Tanaka H, Kawamura A, Mochizuki H, Oyama H. [Tsutsugamushi disease in the foothills of Mt. Fuji (author's transl)]. Kansenshogaku Zasshi. 1980 Jun; 54(6):291-8.
    View in: PubMed
    Score: 0.001
  50. Murata M, Nogami S, Shirasaka A, Tanaka H, Kawamura A, Miyairi T. [Shichito fever in Izu Shichito Islands. 1. Outbreak of Shichito fever and isolation of R. tsutsugamushi from a patient, field rodents and trombiculid mites (author's transl)]. Kansenshogaku Zasshi. 1980 May; 54(5):235-41.
    View in: PubMed
    Score: 0.001
  51. Sawaki S, Kawamura A, Tachibana T. Use of immunological studies in evaluating the clinical course of nasopharyngeal carcinoma. IARC Sci Publ (1971). 1978; (20):575-85.
    View in: PubMed
    Score: 0.001
  52. Sawaki S, Sugano H, Hirayama T, Kawamura A, Tachibana T. Histopathological and immunological studies of nasopharyngeal carcinoma. Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi. 1975 Jun; 8(2):73-81.
    View in: PubMed
    Score: 0.001
  53. Takada M, Murata M, Goto A, Kawamura A, Hung MH. A simple modified method of collecting blood on filter paper for anti-HTV test in seroepidemiological studies on nasopharyngeal carcinoma. Jpn J Exp Med. 1970 Oct; 40(5):391-4.
    View in: PubMed
    Score: 0.000
  54. Kusano N, Aoyama Y, Kawamura A, Kawashima H. The diagnosis of Japanese encephalitis by means of fluorescent antibody technique in autopsy cases. Neuropatol Pol. 1966 Jul-Dec; 4(3):449-56.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support